INTRODUCTION {#h0.0}
============

The severe diarrheal disease cholera is caused by pathogenic strains of the Gram-negative bacterial species *Vibrio cholerae*. All *V. cholerae* strains are native inhabitants of marine and estuarine environments, but a distinguishing feature of the pathogenic strains is their ability to adapt to growth in the human host, producing toxins that facilitate shedding in the stool and reentry into the environment. The transition of *V. cholerae* from its natural aquatic habitat to the human host requires a rapid response to radical environmental changes. How *V. cholerae* senses its environment and incorporates these signals into the regulation of its gene and protein expression profiles is a topic of active research.

One of the primary regulators of gene expression leading to survival, colonization, and production of disease in the mammalian host is the inner membrane-spanning DNA-binding protein ToxR ([@B1][@B2][@B3]). ToxR is at the top of an extensive hierarchy of *V. cholerae* virulence gene regulatory networks (reviewed in references [@B4] and [@B5]). ToxR, together with the transcriptional regulator TcpP, induces expression of the central virulence gene regulator ToxT ([@B6]). ToxT, in turn, activates the genes encoding the toxin-coregulated pilus and the cholera toxin, both of which are required for pathogenesis ([@B4]). ToxR also directly induces expression of the *ctx* genes in the presence of specific compounds such as bile acids ([@B7]), which may act to stimulate the activity of the ToxR protein at its target promoters ([@B8]).

In addition to regulating virulence genes, ToxR is critical for controlling the protein composition of the outer membrane. In response to environmental stimuli, *V. cholerae* remodels its outer membrane to take advantage of different available nutrients and to increase the barrier function of the outer surface. Two of the major outer membrane proteins (OMPs) produced by *V. cholerae* are the porins OmpT and OmpU, both of which are controlled by ToxR ([@B8][@B9][@B10]). ToxR binds directly to the promoter regions of both of these genes, but with opposite effects: whereas *ompU* expression is upregulated by ToxR, *ompT* expression is repressed ([@B10][@B11][@B12]). OmpT has greater overall permeability than OmpU ([@B13]) and is thought to be the dominant porin during growth in the aquatic environment, where the concentration of nutrients and osmolytes may be relatively low. OmpU, although it has a slightly larger pore size than OmpT, is less permeable to negatively charged compounds ([@B13]). Consequently, OmpU is essential for resistance to bile acids and organic acids, as well as to many antimicrobial peptides, present in the digestive tract of the host ([@B14], [@B15]). OmpU is expressed at high levels, both during infection of the human host and during shedding in the stool of cholera patients ([@B16], [@B17]).

The mechanism of ToxR-dependent transcriptional regulation in response to environmental cues is not completely understood. Previous studies have shown that *toxR* expression is not generally responsive to environmental conditions that favor virulence gene expression *in vitro*, suggesting that *toxR* expression may be constitutive under most laboratory conditions ([@B8], [@B18][@B19][@B20]). We have demonstrated, however, that ToxR levels are modulated *in vitro* in response to specific environmental cues. ToxR protein levels increase rapidly in minimal medium upon addition of a mix of asparagine, arginine, glutamate and serine (NRES), and this increase in the level of ToxR is sufficient to promote production of OmpU while reducing synthesis of OmpT ([@B8]). In this study, we demonstrate that modulation of ToxR levels in response to the NRES mix is dependent upon the two-component system VarS/VarA and the global regulator CsrA.

Homologs of the VarS/VarA system are found in many bacterial species, including *Escherichia coli* (BarA/UvrY) and *Pseudomonas* species (GacS/GacA). These systems regulate processes as diverse as central carbon metabolism, motility, biofilm formation, quorum sensing, production of virulence determinants, and oxidative stress (reviewed in references [@B21] and [@B22]). In *V. cholerae*, the VarS/VarA system is involved in carbon metabolism ([@B23]), quorum sensing and biofilm formation ([@B24], [@B25]), expression of virulence determinants ([@B26], [@B27]), fitness in infant mice and rabbits ([@B23], [@B27]), and survival in pond water after being shed from the mammalian host ([@B23]). VarS is predicted to be a sensor kinase that phosphorylates and activates its cognate response regulator VarA in response to an unknown signal. Activated VarA induces transcription of three noncoding small RNAs (sRNAs), CsrB/C/D ([@B25]), which bind the regulatory protein CsrA and sequester it in an inactive state ([Fig. 1](#fig1){ref-type="fig"}). Each of the three *V. cholerae* Csr sRNAs contains multiple CsrA recognition sequences and is predicted to bind 15 to 20 CsrA molecules ([@B25]), as has been shown for the CsrA-antagonizing sRNA CsrB in *E. coli* ([@B28]). CsrA is a global, posttranscriptional regulator that acts by binding to mRNA targets and affecting their translation or stability. CsrA is likely the primary target of signaling through the VarS/A system in *V. cholerae* ([@B25]), but it is not known whether the CsrA/B/C/D system is subject to VarS/A-independent regulation.

![Overview of the VarA/S-CsrB/C/D-CsrA pathway. Dashed arrows indicate that the exact mechanism of regulation is currently unknown. We show here that CsrA positively regulates the level of ToxR protein in response to amino acids. Var/Csr-mediated regulation of biofilm and virulence gene expression via the quorum sensing pathway is described by Lenz et al. ([@B25]). The regulation of *omp* gene expression by ToxR is well established ([@B8], [@B10], [@B14]).](mbo0041524120001){#fig1}

We show here that a *varA* mutant of *V. cholerae*, which is predicted to overproduce active CsrA due to poor expression of the CsrB/C/D sRNAs, had elevated levels of ToxR and OmpU in the absence of the NRES signal. This suggests that CsrA has a stimulatory effect on ToxR levels. Consistent with this, we identified a series of CsrA point mutants that failed to increase ToxR levels or produce OmpU in response to the NRES mix. One of these point mutants, CsrA Arg6His, was tested *in vivo* and failed to colonize infant mice, showing that CsrA is critical for the virulence of *V. cholerae*. The interconnection of the CsrA global regulatory circuit with the ToxR regulon has important implications for how *V. cholerae* incorporates environmental cues into the complex regulation of its virulence genes.

RESULTS {#h1}
=======

The transcriptional profile of *V. cholerae* in response to NRES. {#s1.1}
-----------------------------------------------------------------

Our previous studies demonstrated that growth of *V. cholerae* in a minimal medium containing the NRES amino acid mix caused ToxR levels to increase, resulting in a switch in the dominant porin from OmpT to OmpU ([@B8]). To better understand the nature of the response to amino acid stimulation in *V. cholerae*, changes in *V. cholerae* gene expression in response to the NRES mix were determined by microarray analysis. A list of *V. cholerae* genes for which the transcript level was altered more than 2-fold in response to NRES can be found in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. These include genes involved in amino acid and carbon metabolism, peptide transporter genes, genes related to quorum sensing, biofilm formation, and chemotaxis, virulence genes, including *toxR*, *toxS*, and *varA*, iron transport genes, a putative σ^54^ modulation factor gene, the porin genes *ompT* and *ompU*, genes encoding hypothetical proteins, and many others. Several of the NRES-responsive genes were tested by mutant analysis to determine whether they played a role in the NRES-dependent ToxR increase and OMP switching (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material). As expected, *toxR* and *toxS* mutants did not produce OmpU under any condition ([@B8]); however, only one additional NRES-regulated gene tested in this study, *varA*, displayed a mutant phenotype with respect to its OMP profile. Other genes known to play a role in the virulence of *V. cholerae* were tested as well, but none were found to be required for OMP switching in response to NRES ([Table S2](#tabS2){ref-type="supplementary-material"}), making it unlikely that they participate in NRES-mediated regulation of ToxR levels.

VarA plays a role in the NRES response. {#s1.2}
---------------------------------------

The VarS/A system is involved in quorum sensing and virulence gene regulation in *V. cholerae* ([@B25][@B26][@B27]). Interestingly, the gene encoding the response regulator VarA showed a 2- to 3-fold induction in the presence of NRES. Therefore, a *varA* mutant was constructed in *V. cholerae* El Tor strain N16961 and tested for its ability to respond to the NRES mix.

The N16961 *varA* mutant (N*varA*) produced a mixture of large and small colonies. The small-colony variant, N*varA*~S~, exhibited reduced growth in liquid culture compared with the wild-type parental strain, especially in a minimal medium ([Fig. 2A](#fig2){ref-type="fig"}). Growth was restored to wild-type levels when pVarA, a low-copy-number plasmid containing the cloned *varA* gene, was introduced into the N*varA*~S~ strain ([Fig. 2A](#fig2){ref-type="fig"}), showing that the poor growth of N*varA*~S~ was due solely to the lack of a functional VarA.

![Mutation of *varA* causes growth defects and results in an abnormal pattern of OMP and ToxR expression. (A) N16961 (WT), the Δ*varA*::*cam* mutant (N*varA*~S~), the vector control strain N*varA*~S~/pWKS30, and the complemented strain N*varA*~S~/pVarA were grown overnight in LB broth and then subcultured 1:100 into fresh LB or T medium and grown for 6 h. (B) N16961 and N*varA*~S~ were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (top panel) or immunoblotted using polyclonal anti-ToxR antisera (bottom panel).](mbo0041524120002){#fig2}

When grown in a minimal medium, the N*varA*~S~ strain had an abnormal OMP profile, producing both OmpT and OmpU, whether or not NRES was present ([Fig. 2B](#fig2){ref-type="fig"}). Alterations in the OMP profile often indicate misregulation of ToxR levels. Indeed, in the absence of amino acids, the level of ToxR was much higher in the N*varA*~S~ strain than in the parental strain ([Fig. 2B](#fig2){ref-type="fig"}). This increase in ToxR could reasonably account for the presence of OmpU in the N*varA*~S~ strain grown without any added NRES, as an increase in ToxR protein levels above basal levels is sufficient to induce *ompU* expression ([@B8]).

In contrast to N*varA*~S~, the large-colony N*varA* strain (N*varA*~L~) had a normal growth phenotype compared with its wild-type parental strain (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) but did not produce any OmpU in response to NRES when grown in a minimal medium ([Fig. 3A](#fig3){ref-type="fig"}). This was not due to an inherent inability to synthesize OmpU, since N*varA*~L~ made OmpU exclusively when grown in medium containing the bile salt cholate ([Fig. 3B](#fig3){ref-type="fig"}), a condition known to promote the production of OmpU and repress the synthesis of OmpT ([@B8]). These data suggest that N*varA*~L~ specifically cannot respond to NRES. The switch from *ompT* to *ompU* expression in response to NRES requires an increase in the level of ToxR, unlike the response to bile acids, in which the ToxR level is unchanged ([@B8]). To determine whether the inability to produce OmpU in the N*varA*~L~ strain is due to failure to upregulate the production of ToxR in response to the NRES mix, ToxR levels were assessed. The results show that ToxR levels did not increase in N*varA*~L~ grown with NRES ([Fig. 3A](#fig3){ref-type="fig"}), suggesting that the level of ToxR is insufficient to promote a switch in *omp* gene expression from *ompT* to *ompU* under these conditions.

![(A) The N*varA*~L~ mutant did not increase OmpU or ToxR levels in response to NRES. This phenotype could not be complemented with pVarA, suggesting a suppressor mutation. Strains N16961 (WT), N*varA*~L~, N*varA*~L~/pWKS30 (vector control), and N*varA*~L~/pVarA (complemented strain) were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (top panel) or immunoblotted using polyclonal anti-ToxR antisera (bottom panel). (B) The N*varA*~L~ strain did not have an inherent defect in OmpU production, since OmpU was made exclusively in response to the bile acid cholate. Strains N16961 (WT) and N*varA*~L~ were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 0.1% cholate. Cells were harvested in the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained with Coomassie blue to visualize the OMPs.](mbo0041524120003){#fig3}

When pVarA was introduced into N*varA*~L~ for complementation, it did not restore NRES-mediated OmpU production, nor did it cause an increase in ToxR levels in response to NRES ([Fig. 3A](#fig3){ref-type="fig"}). This suggested that the N*varA*~L~ strain contains a suppressor mutation that allows for relatively robust growth compared with the N*varA*~S~ strain but which disrupts the induction of ToxR and OmpU levels in response to NRES.

Loss of VarA results in suppressor mutations in *csrA*. {#s1.3}
-------------------------------------------------------

Since loss of VarA is predicted to result in overaccumulation of active CsrA due to low levels of the CsrA-sequestering sRNAs ([Fig. 1](#fig1){ref-type="fig"}), we reasoned that suppressor mutations could arise in the *csrA* gene itself. The *csrA* gene from the N*varA*~L~ strain was sequenced and was found to contain a point mutation that replaces the arginine residue at amino acid position 6 with a histidine (R6H). Several independently derived N*varA*~L~ isolates were analyzed to determine whether they also carried suppressor mutations in *csrA* and whether there was variation in the type of *csrA* point mutation that could arise in the absence of functional VarA. All of the N*varA*~L~ isolates tested carried point mutations affecting *csrA*. In contrast, none of the small colony phenotype N*varA*~S~ strains had mutations in *csrA*. Most of the N*varA*~L~ strain mutations were in the *csrA* coding region, but several isolates carried mutations in the predicted Shine-Dalgarno (SD) sequence upstream of the *csrA* translational start ([Fig. 4](#fig4){ref-type="fig"}). All coding region mutations resulted in a single amino acid substitution in CsrA ([Fig. 4](#fig4){ref-type="fig"}). The OMP profiles of several N*varA*~L~ suppressor mutants were analyzed. Many of these mutants did not produce OmpU in response to the NRES mix ([Fig. 5A](#fig5){ref-type="fig"}). Rather, they produced OmpT at high levels in minimal medium both with and without NRES supplementation. Thus, these mutants were not stimulated to switch OMPs in the presence of NRES. The amino acid substitutions in this group of mutants generally clustered in the N-terminal half of CsrA (R6H, R6L, T11P, I14T, and T19P) ([Fig. 4](#fig4){ref-type="fig"}). Another class of point mutants produced both OmpT and OmpU in T medium alone, and this pattern did not change with the addition of NRES, suggesting defects in OMP regulation in response to environmental cues ([Fig. 5A](#fig5){ref-type="fig"}). Several mutants of this class had amino acid substitutions localizing to a region within the C-terminal half of the CsrA protein (A36S and P37L) ([Fig. 4](#fig4){ref-type="fig"}). Some of the suppressor strains had mutations in the putative SD sequence ([Fig. 4](#fig4){ref-type="fig"}). These mutants were phenotypically similar to the class of mutants exhibiting no OmpU production in response to NRES ([Fig. 5A](#fig5){ref-type="fig"}; also data not shown).

![Sequence conservation, structural features, and locations of suppressor mutations in *V. cholerae* CsrA. (A) An alignment of the *V. cholerae* CsrA protein with CsrA from additional Gram-negative species, *E. coli*, *Salmonella enterica* serovar Typhimurium, and *Pseudomonas aeruginosa*, showing a high degree of conservation among these species. The positions of the predicted β sheets (β1 to β5) and α helix (α1) in the CsrA protein are indicated above the alignment. The colored arrows point to the positions of the CsrA suppressor mutations relative to the secondary structural elements. The angled black arrow shows the translational start of the *csrA* open reading frame. The mutated residues in the suppressor strains are highlighted in the *V. cholerae* CsrA protein sequence. The thick arrows above the alignment show the positions of the transposon insertions within the published *E. coli csrA*::*kan* (open arrow) ([@B29]) and *V. cholerae csrA*::Tn*5* (closed arrow) ([@B25]) mutant strains. (B) List of the CsrA point mutations identified in the N*varA*~L~ and the N*toxR*, *varA*~L~ suppressor strains (color coded to match the arrows in panel A), their phenotypes with respect to OMP and ToxR production, and their frequency of isolation. The ARM759~L~ strains were not tested for their NRES response, since they are *toxR* mutants and do not make OmpU. The N*varA*~L~ suppressor mutants are in the *V. cholerae* N16961 Δ*varA*::*cam* background, and the ARM759~L~ suppressor mutants are in the N16961 Δ*toxR*::*kan* Δ*varA*::*cam* background.](mbo0041524120004){#fig4}

![The N*varA*~L~ suppressor strains show abnormal responses to the NRES mix. Strains are labeled according to the *csrA* suppressor mutation present, but all mutant strains additionally carry the Δ*varA*::*cam* mutation. Strains N16961 (wild type \[WT\]), N*varA*~L~-00 (SD\*), N*varA*~L~-1 (R6H), N*varA*~L~-2 (R6L), N*varA*~L~-3 (T11P), N*varA*~L~-4 (I14T), N*varA*~L~-6 (A36S), and N*varA*~L~-7 (P37L) were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (A) or immunoblotted using polyclonal anti-ToxR antisera (B).](mbo0041524120005){#fig5}

The level of ToxR was determined in each of these suppressor mutants. In the mutants producing no detectable OmpU in response to NRES, the level of ToxR was found to be correspondingly low, indicating that the point mutations in CsrA abolished the NRES-mediated increase in ToxR protein levels ([Fig. 5B](#fig5){ref-type="fig"}). In the strains that produced a small, constitutive amount of OmpU with or without NRES, the level of ToxR protein was higher than normal in the absence of NRES but lower than normal in the presence of NRES ([Fig. 5B](#fig5){ref-type="fig"}); thus, the amount of ToxR produced was large enough to promote some OmpU synthesis in the absence of NRES but not sufficient to cause a complete switch in OMP production from OmpT to OmpU ([Fig. 5A](#fig5){ref-type="fig"}). The inappropriate production of ToxR and OmpU in the absence of NRES seen in this group of N*varA*~L~ suppressor strains might result from constitutively high levels of free (albeit less active) mutant CsrA, since the *varA* mutant strains do not produce the CsrA-sequestering sRNAs ([Fig. 1](#fig1){ref-type="fig"}).

High levels of active CsrA cause growth defects and overproduction of ToxR and OmpU in the absence of NRES. {#s1.4}
-----------------------------------------------------------------------------------------------------------

Complementation experiments were carried out in order to rescue the *csrA* defect of the N*varA*~L~ mutant strains by supplying the *csrA* gene on a low-copy-number vector; however, the mutant strains did not tolerate the *csrA* plasmid well, and most of the strains failed to maintain the plasmid. This is not surprising, since the *varA* mutation impairs the ability of the strain to control the level of free CsrA, which is likely detrimental for growth, as shown above. Only one of the N*varA*~L~ strains, N*varA*~L~-3 (Δ*varA*::*cam csrA*.T11P), maintained the pWCsrA plasmid well enough for analysis. This strain exhibited very poor growth when carrying the pWCsrA plasmid but normal growth when carrying the vector alone ([Fig. 6A](#fig6){ref-type="fig"}). The presence of the pWCsrA plasmid did not restore the OMP profile to normal. Rather, OmpU was inappropriately expressed when the mutant strain carrying this plasmid was grown in T medium alone ([Fig. 6B](#fig6){ref-type="fig"}), suggesting overproduction of ToxR, even in the absence of an environmental cue. This is likely due to constitutively high levels of free CsrA in the absence of a functional VarA system and suggests that CsrA acts as a positive regulator of ToxR synthesis. The pWCsrA plasmid had no effect on the OMP profile of the wild-type strain grown with or without the NRES supplement (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). This is consistent with tight regulation of CsrA levels by the VarS/A-CsrB/C/D system in the wild-type strain to prevent toxic levels of free CsrA.

![An N*varA*~L~ suppressor mutant cannot be complemented by supplying wild-type *csrA* on a plasmid. Expression of wild-type CsrA in the absence of functional VarA is toxic to the cells, and leads to production of OmpU in the absence of NRES. (A) Strains N16961 (WT), N*varA*~L~-3 (Δ*varA*::*cam csrA*.T11P), N*varA*~L~-3/pWKS30, and N*varA*~L~-3/pWCsrA were grown overnight in LB broth and then subcultured 1:100 into fresh LB broth and grown to the stationary phase. (B) Strains N16961 (wild type \[WT\]), N*varA*~L~-3/pWKS30, and N*varA*~L~-3/pWCsrA were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue.](mbo0041524120006){#fig6}

An Arg6His substitution in CsrA is sufficient to abolish NRES-mediated ToxR production. {#s1.5}
---------------------------------------------------------------------------------------

To test directly the role of CsrA in the regulation of ToxR protein levels, attempts were made to delete the entire *csrA* gene in strain N16961; however, none of these attempts was successful, suggesting that *csrA* is essential in *V. cholerae*. Instead, we tested whether a point mutation in CsrA alone is sufficient to abolish the ToxR/OMP response to the NRES mix. The *csrA* R6H point mutation, which was one of the most frequently isolated mutations, was constructed in the wild-type genetic background. The N*csrA*.R6H strain exhibited wild-type growth (data not shown) but produced only OmpT, and no OmpU, in the presence of the NRES mix ([Fig. 7A](#fig7){ref-type="fig"}), indicating that the *csrA* point mutation, and not the *varA* deletion, caused the failure to respond to the NRES mix in the original N*varA*~L~-1 strain. As in the N*varA*~L~-1 strain, the ToxR levels in the N*csrA*.R6H point mutant did not increase in the presence of NRES ([Fig. 7B](#fig7){ref-type="fig"}). This shows that changing just a single amino acid in CsrA profoundly affects the ability of *V. cholerae* to respond to amino acids. To verify that the N*csrA*.R6H point mutant did not contain any additional suppressor mutations that might be responsible for the observed phenotype, the point mutant was complemented. A *csrA* plasmid clone was created in a single-copy-number vector, pCC1. When pFCsrA was introduced into N*csrA*.R6H, both the OMP profile and the ToxR level were restored to wild type ([Fig. 7A](#fig7){ref-type="fig"} and [B](#fig7){ref-type="fig"}). This shows that the R6H point mutation in CsrA is solely responsible for the defect in ToxR/OmpU production. Expression of *csrA* from the pFCsrA plasmid did not interfere with regulation of the OMPs in the wild-type strain (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material), most likely due to tight regulation of free CsrA levels by the VarS/A-CsrB/C/D system.

![An Arg6His substitution in CsrA is sufficient to abolish the response to NRES, even when the Var system is functional. The wild-type strain N16961, the N*csrA*.R6H mutant, the vector control strain N*csrA*.R6H/pCC1, and the complemented strain N*csrA*.R6H/pFCsrA were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (A) or immunoblotted using polyclonal anti-ToxR antisera (B).](mbo0041524120007){#fig7}

A *csrA*::Tn*5* carboxy-terminal insertion mutant is defective in NRES-mediated ToxR production. {#s1.6}
------------------------------------------------------------------------------------------------

Although we were unable to create a *csrA* deletion mutant in *V. cholerae*, a *csrA*::Tn*5* mutant has been isolated and shown to affect quorum sensing pathways in *V. cholerae* strain C6706str2 ([@B25]). Interestingly, when the *csrA*::Tn*5* allele was sequenced, we found that the site of the Tn*5* insertion was at the end of the *csrA* gene, in a position nearly identical to the transposon insertion in a published, viable *E. coli csrA*::*kan* mutant ([@B29], [@B30]) ([Fig. 4](#fig4){ref-type="fig"}). This suggests that the *V. cholerae csrA*::Tn*5* mutant, like the *E. coli csrA*::*kan* mutant, may produce a partially functional CsrA. This is further supported by the absence of any growth defect in the *V. cholerae csrA*::Tn*5* mutant ([@B25]; also data not shown). An identical *csrA*::Tn*5* insertion mutation was created in strain N16961. As shown in [Fig. 4](#fig4){ref-type="fig"}, this insertion results in the loss of the C-terminal 12 amino acid residues of *V. cholerae* CsrA. N*csrA*::Tn*5* exhibited wild-type growth in rich medium (data not shown), suggesting that the C-terminally truncated CsrA protein retains the activities needed for viability; however, similar to the N*csrA*.R6H strain, N*csrA*::Tn*5* produced very low levels of ToxR and OmpU in response to NRES (see [Fig. S3A](#figS3){ref-type="supplementary-material"} and [B](#figS3){ref-type="supplementary-material"} in the supplemental material). Wild-type OMP and ToxR levels were fully restored when *csrA* was supplied on plasmid pFCsrA (see [Fig. S3A](#figS3){ref-type="supplementary-material"} and [B](#figS3){ref-type="supplementary-material"}).

The outgrowth of *csrA* suppressor mutants is not due to overproduction of a ToxR-regulated target. {#s1.7}
---------------------------------------------------------------------------------------------------

As described in [Fig. 1](#fig1){ref-type="fig"}, mutation of *varA* leads to an increase in the level of free CsrA and therefore in the level of ToxR. Thus, the selective pressure to mutate *csrA* in a *varA* mutant strain background could be a result of overproduction of a ToxR-activated target, such as OmpU, in the *varA* mutant. To investigate this, a *varA* deletion was created in a *toxR*-defective strain. Both large and small colonies were observed for the resulting *toxR varA* mutants, suggesting the outgrowth of suppressor mutants (large colonies). The *csrA* gene was sequenced in a number of these double mutants. All large colonies had *csrA* point mutations ([Fig. 4](#fig4){ref-type="fig"}), whereas the small colonies were wild type for *csrA.* This demonstrates that suppressor mutations leading to improved growth of the *varA* mutant are selected for even in the absence of *toxR*, showing that misregulation of a ToxR-activated gene is unlikely to be the selective pressure responsible for the outgrowth of *csrA* suppressors in the *varA* mutant. Thus, the pressure to mutate *csrA* in the absence of *varA* may be due to misregulation of another, unknown, CsrA target.

HapR and LuxO are not needed for the NRES response. {#s1.8}
---------------------------------------------------

*V. cholerae* CsrA has been shown to regulate the expression of genes involved in quorum sensing, biofilm formation, and virulence, primarily through the regulatory protein HapR, which integrates signals from multiple pathways, including the Lux quorum sensing pathway and the VarS/A-CsrA system ([@B25], [@B31]). The strain used in these studies, N16961, is naturally defective for *hapR* ([@B32]), suggesting that HapR is not needed for NRES-mediated regulation. Although N16961 does not produce functional HapR, it may produce another factor with a redundant function. To determine directly whether either quorum sensing or HapR plays a role in the CsrA-mediated regulation of ToxR levels in response to NRES, we tested the effects of various mutations in a HapR^+^ strain, C6706, which responds similarly to NRES as N16961 (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material). Similar to the N*varA*~S~ strain, a C6706 *varA* mutant grew poorly and produced ToxR and OmpU in the absence of NRES, all of which could be remedied by supplying wild-type *varA* on a plasmid (data not shown). These data suggest that C6706 does not differ significantly from the HapR-defective N16961 strain in its response to NRES and the role of VarA in this; however, it did not rule out that HapR is needed for some aspect of this response in C6706. Therefore, a C6706 *hapR* mutant was tested for its role in the NRES regulation. No differences were detected between the wild-type parental strain and the *hapR* mutant with respect to OMP and ToxR levels in the presence of NRES (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material), indicating that HapR is not required for the NRES response. The quorum sensing regulator, LuxO, which has been shown to play a role in relaying input from the Var/Csr pathway into the quorum sensing pathway ([@B25]), was not necessary for the NRES response either (see [Table S2](#tabS2){ref-type="supplementary-material"}). This suggests that the mechanism of CsrA regulation of ToxR levels does not require either the Lux quorum sensing pathway or the HapR transcriptional regulator.

CsrA is required for virulence. {#s1.9}
-------------------------------

ToxR is a critical virulence factor within the mammalian host ([@B4], [@B33], [@B34]), suggesting that functional CsrA may also be necessary for the pathogenesis of *V. cholerae*. To test this, we assessed the ability of the N*csrA*.R6H mutant to colonize infant mice. The infant mouse model has been shown to be effective in demonstrating the importance of many major virulence factors in this pathogen ([@B35]). A competition assay was performed to compare the *in vivo* fitness of the N*csrA*.R6H point mutant to that of the wild-type strain. As described earlier, the N*csrA*.R6H strain was not impaired in its *in vitro* growth but failed to increase ToxR and OmpU levels in response to the NRES mix. Five-day-old infant mice were inoculated intragastrically with equal numbers of the wild-type strain and the N*csrA*.R6H mutant. The ability of the mutant strain to compete with the wild-type strain was assessed by determining the ratio of viable mutant cells to wild-type cells recovered after 18 h. The median competitive index (CI \[i.e., the output ratio normalized to the input ratio\]) for the N*csrA*.R6H mutant was \<0.01, showing a severe defect in the ability to colonize the infant mouse ([Fig. 8](#fig8){ref-type="fig"}). Four of the nine animals yielded results that were below the limit of detection (CI, \<0.005), and therefore the median CI is likely even lower than what was computed. These data point to an overall decrease in fitness of more than 100-fold for the mutant strain, showing that CsrA is critical for colonization of the small intestine.

![CsrA is required for *V. cholerae* virulence in infant mice. The CsrA Arg6His point mutant N*csrA*.R6H was competed against the wild-type strain N16961G. Five-day-old suckling BALB/c mice were inoculated intragastrically with an equal number of each competing strain as described in Materials and Methods. The competitive index (CI) was calculated by normalizing the output ratio to the input ratio of the two competing strains. Each data point represents one mouse, and the median CI (0.01) is represented by the solid horizontal line. A CI value below 1 indicates that the mutant is at a competitive disadvantage. The dotted line shows the limit of detection for the CI in this experiment, which was 0.005. In 4 out of 9 mice, the mutant was not detected during analysis of more than 200 recovered colonies, and thus the CI falls below the limit of detection. These data points are included in the analysis as having a value of 0.005, which is the most conservative estimate for the CI. The actual CI values are likely to be lower. The results were statistically significant (*P* \< 0.05) by the Mann-Whitney nonparametric test.](mbo0041524120008){#fig8}

DISCUSSION {#h2}
==========

*V. cholerae* is a facultative human pathogen that spends most of its life cycle in aquatic habitats. The transition to the human host represents a major environmental shift that includes changes in temperature, pH, osmolarity, and the level of both nutrients and antimicrobial compounds. *V. cholerae* must sense and respond to these environmental cues in order to survive the initial transit through the upper portions of the digestive tract and become oriented toward the most favorable microenvironment for successful colonization and production of the cholera toxin within the lower part of the small intestine.

In *V. cholerae*, as well as in other human pathogens, the global regulator CsrA plays an important role in coordinating the cellular response to multiple environmental signals, including nutritional status and cell density ([@B23], [@B25], [@B36]). In this study, we demonstrate a link between CsrA and regulation of ToxR levels in response to an environmental signal. CsrA was essential for the increase in ToxR that occurred when *V. cholerae* grew in the presence of the NRES amino acids and for the subsequent alterations in the outer membrane protein profile. We show further that CsrA is critical for the virulence of *V. cholerae*; this is the first definitive study of the role of *V. cholerae* CsrA *in vivo*.

CsrA was shown previously to affect pathways leading to virulence gene expression in *V. cholerae*, but not via ToxR. Most of the effects of the CsrA signaling cascade on virulence gene expression in *V. cholerae* have been found to be relayed through HapR, either via quorum sensing and the Lux pathway ([@B25]) or through Lux-independent effects on HapR activity ([@B37]). HapR-independent regulation of a virulence gene by CsrA has not been demonstrated. However, in at least one HapR^−^ strain of *V. cholerae*, O395 ([@B38]), VarA is required for production of virulence factors and for pathogenesis in mice ([@B27]). This suggests that there is HapR-independent regulation of the *V. cholerae* virulence regulon through the Var/Csr system. Here, we show that the interconnection between the CsrA pathway and the ToxR regulon occurs independently of both HapR and the central quorum sensing regulator LuxO.

Our data suggest a model in which CsrA acts as a positive regulator of ToxR synthesis. A *V. cholerae* VarA system mutant, which is predicted to produce too much active CsrA ([@B25]), exhibited abnormally high levels of ToxR and OmpU in minimal medium without amino acid supplementation. Overexpression of *csrA* from a plasmid in the absence of functional VarA caused a similar increase in ToxR and OmpU levels in the absence of the NRES signal. In addition, mutation of *csrA*, either through a point mutation or a transposon insertion, was associated with failure to upregulate ToxR levels in the presence of NRES, further establishing the requirement for CsrA in the ToxR-mediated response to amino acids.

CsrA can act as a positive or a negative regulator, depending on whether it increases or decreases either translation or stability of the target mRNA (reviewed in reference [@B22]). Studies are under way to determine whether the observed positive effects of CsrA on ToxR regulation are direct or indirect. Putative binding sites for CsrA can be found in the region upstream of the predicted start of translation of the *toxR* mRNA (A. R. Mey, unpublished results), suggesting that CsrA may bind directly to the *toxR* transcript and increase its stability or rate of translation. The exact mechanism for this proposed regulation is not clear, since the putative CsrA binding sites are in close proximity to the proposed Shine-Dalgarno sequence in the predicted *toxR* transcript, which is more typical of translational repression. It should be noted, however, that experimental verification of the predicted start sites for *toxR* transcription and translation in *V. cholerae* has not been published. At least one study has suggested an alternative start of translation for ToxR ([@B39]), and this could have implications for the mechanism by which CsrA influences ToxR levels. In addition, new mechanisms of regulation by CsrA are still being uncovered, and there is much still to learn about how this important global regulator operates at its various mRNA targets.

Our studies suggest that *csrA* is essential in *V. cholerae*, as we were unable to construct a complete deletion of the *csrA* gene. In *E. coli*, CsrA is essential under laboratory conditions ([@B30]), and most published studies of *csrA* function in *E. coli* have been carried out using a strain carrying a transposon insertion at codon 51 out of 65 ([Fig. 4](#fig4){ref-type="fig"}), resulting in a partially active CsrA protein ([@B29], [@B30]). The published, viable *V. cholerae csrA*::Tn*5* mutant carries an insertion in a similar position, suggesting that it may also retain partial CsrA activity. It has been proposed that the lethality of a *csrA* null mutant could be due in part to accumulation of excess glycogen ([@B30]), since CsrA is known to repress the glycogen biosynthetic pathway ([@B29]); however, we were unable generate a complete *csrA* deletion mutant in a glycogen synthesis-deficient strain of N16961 ([@B40]), suggesting that *csrA* is essential for the growth of *V. cholerae* for reasons other than or in addition to regulation of glycogen biosynthesis (H. A. Butz, unpublished results).

While loss of *csrA* is harmful to the cell, too much CsrA is detrimental as well. The level of active CsrA is tightly controlled through the CsrB/C/D sRNAs and by the VarS/VarA two-component system that regulates their expression. Our studies suggest that a constitutively high level of active CsrA through loss of VarA in *V. cholerae* causes growth defects, resulting in the accumulation of suppressor mutations in *csrA.* The *varA csrA\** suppressor strains exhibited normal growth compared with the *varA* mutant alone, but poor growth returned when wild-type *csrA* was supplied on a plasmid, further evidence that overproduction of active CsrA is damaging to the cell. A suppressor mutation in the *csrA* gene was identified also by Kamp et al. ([@B23]) during their studies of a *V. cholerae* El Tor strain E7946 *varS* mutant. The mutation was mapped to the start codon of *csrA* and was predicted to decrease the amount of CsrA made. Kamp et al. noted that the *varS csrA*\* suppressor strain survived nutrient-limiting conditions far better than the *varS* mutant alone, suggesting that high levels of active CsrA impaired growth in this strain as well. A high rate of suppressor mutations in response to misregulation of CsrA levels has not been reported in other bacterial species. In *E. coli*, mutants with mutations in the BarA/UvrY two-component system do not grow poorly except when glycolytic carbon sources are used ([@B41]), and no *csrA* suppressor mutations have been reported for these mutant strains. Not surprisingly, active CsrA levels are tightly controlled in *E. coli* and subject to multiple checkpoints and feedback loops ([@B42], [@B43]).

An important question that remains is how the NRES amino acids control the level of active CsrA. The specific sensing mechanism for the NRES mix is not known, and it is unclear whether the VarS/A system is responsible for relaying the NRES signal. The transcriptional profile of *V. cholerae* in response to NRES showed no changes in the level of the *varS* and *csrA* transcripts, while the level of the *varA* transcript was increased. An increase in VarA should lower the level of active CsrA, but instead, active CsrA levels were higher in the presence of NRES. The increase in *varA* transcript levels could be due to feedback regulation from CsrA, since CsrA has been shown to positively affect transcription of the *varA* homolog *uvrY* in *E. coli* ([@B43]). In *E. coli*, CsrB sRNA levels were greatly reduced when cells were grown in the presence of amino acids ([@B44]), which could lead to an increase in active CsrA levels. We are currently investigating whether this may also be the case in *V. cholerae*.

*V. cholerae* CsrA is a small, 65-amino-acid protein with 84% amino acid identity to *E. coli* CsrA ([Fig. 4](#fig4){ref-type="fig"}). The three-dimensional structure of CsrA (or its homologs RsmA/RsmE) has been solved in *E. coli* ([@B45]), *Pseudomonas putida* ([@B46]), *Pseudomonas fluorescens* ([@B47]), and *Yersinia enterocolitica* ([@B48]). Based on the high level of amino acid conservation between these proteins and *V. cholerae* CsrA, it is likely that *V. cholerae* CsrA is very similar in structure. In these structures, CsrA is a homodimeric barrel-shaped protein made up of intertwined β sheets from each of the CsrA subunits, with two wing-like α-helical extensions. Alanine-scanning mutagenesis identified two regions of CsrA that are in close proximity to each other and that are critical for both RNA binding and regulatory activity ([@B49]). These regions encompass the first (amino acid residues 2 to 7) and the fifth (amino acid residues 40 to 47) β strands of CsrA ([Fig. 4](#fig4){ref-type="fig"}). β strand 1 is the most highly conserved region among CsrA proteins from a diverse range of bacterial species, and several residues in β strand 5 are invariable as well ([@B49]) ([Fig. 4](#fig4){ref-type="fig"}). β strand 1 from one CsrA subunit interdigitates with β strand 5 from the other subunit to form one of the two positively charged, solvent-accessible faces of the dimer. These are the regions of the CsrA dimer believed to be primarily involved in binding RNA. A large proportion of the point mutants isolated in this study clustered within the first β strand or in the region immediately following, confirming the importance of the N-terminal domain for CsrA function ([Fig. 4](#fig4){ref-type="fig"}). Arg6 was one of the most commonly mutated residues in *V. cholerae* CsrA in response to misregulation of CsrA levels in the *varA* mutant. It was shown in *Pseudomonas fluorescens* that an R6A substitution in the CsrA homolog RsmE, which has been cocrystallized with its target mRNA, *hcnA* ([@B47]), was associated with a complete failure to repress translation of the *hcnA* transcript ([@B50]), pointing to the critical nature of this residue. It was also demonstrated by structural analyses of *Y. enterocolitica* RsmE that Arg6 forms an important salt bridge with Glu46 which helps to stabilize the α-helical extension from each face of the dimer ([@B48]). Not surprisingly, a truncation of the C terminus was associated with defects in CsrA function, likely due to effects on the α helix and the adjacent RNA-binding domain. It is important to reiterate that the point mutants, as well as the *csrA*::Tn*5* insertion mutant, obtained in this study retained some vital functions of CsrA, since the strains did not exhibit the growth defects associated with either overproduction or the complete absence of active CsrA.

Because *csrA* is essential, it has been difficult to study the role of CsrA in virulence. We show here that mutation of a single amino acid residue of CsrA is sufficient to abolish its ability to mediate an increase in the level of a major virulence gene regulator, ToxR, in response to amino acids. The N*csrA*.R6H point mutant exhibited no growth defects *in vitro* compared with its wild-type parental strain; however, the mutation had a profound effect on the ability of *V. cholerae* to colonize infant mice. ToxR is one of the most important regulators of virulence gene expression in this pathogen. ToxR controls expression of the major *V. cholerae* virulence factors ([@B4], [@B5]) and is essential for causing disease in both humans and mice ([@B33], [@B34]). This might suggest that the ability to regulate ToxR levels in response to certain nutrients could be important *in vivo*; however, it is important to recognize that CsrA is a global regulator with pleiotropic effects on carbon metabolism, quorum sensing, biofilm production, and other processes that could influence the ability of *V. cholerae* to cause disease in the mammalian host. Our studies cannot distinguish between the CsrA-mediated increase in ToxR levels and another function of CsrA needed for colonization and virulence; nevertheless, these studies have demonstrated a clear requirement for CsrA in *V. cholerae* pathogenesis separate from its essential viability functions, and we have uncovered a previously unknown relationship between CsrA and ToxR. The regulation of ToxR levels by CsrA in response to amino acids adds another dimension to the complex network of transcriptional, translational, and posttranslational mechanisms for ensuring maximal ToxR activity at the appropriate times within the diverse environments occupied by this important pathogen.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and plasmids, and growth conditions. {#s3.1}
------------------------------------------------------

Bacterial strains and plasmids used in this study are listed in [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material. All strains were maintained at −80°C in tryptic soy broth (TSB) plus 20% glycerol. Strains were routinely grown at 37°C in Luria-Bertani (LB) broth (1% tryptone, 0.5% yeast extract, 1% NaCl \[wt/vol\]) ([@B51]) or in T medium ([@B52]) modified to contain 0.2% wt/vol sucrose, 20 µM FeSO~4~, and a mixture of vitamins (recipe for 100× VA vitamin solution at <http://www.genome.wisc.edu/resources/protocols/ezmedium.htm>). Amino acids (Sigma) for the NRES supplement were dissolved in water and used at a final concentration of 12.5 mM total amino acids (3.125 mM each amino acid), unless otherwise indicated. Cholate was used at 0.1% (wt/vol). Antibiotics were used at the following concentrations for *E. coli* strains: 50 µg/ml ampicillin, 50 µg/ml kanamycin, and 30 µg/ml chloramphenicol. For *V. cholerae* strains, the concentrations used were 25 µg/ml ampicillin, 25 µg/ml kanamycin, 6 µg/ml chloramphenicol, 30 µg/ml gentamicin, and 20 µg/ml polymyxin B.

Plasmid clones were transferred to *V. cholerae* strains by electroporation or bacterial conjugation, as described previously ([@B53]).

PCR. {#s3.2}
----

The oligonucleotide primers for PCR were purchased from Sigma-Aldrich (St. Louis, MO) and Invitrogen (Carlsbad, CA). Primers used for cloning are listed in [Table S4](#tabS4){ref-type="supplementary-material"} in the supplemental material. PCR was performed using KOD Hot Start DNA polymerase (Novagen, EMD Chemicals, San Diego, CA) to create fragments for cloning and *Taq* DNA polymerase (Qiagen, Valencia, CA) for all general verification purposes. PCRs were carried out according to the manufacturer's instructions, using the primers described below. Unless otherwise indicated, the template for PCR was bacterial whole-cell suspensions in water. All clones derived from PCR products were verified by DNA sequencing.

Sequence analysis. {#s3.3}
------------------

DNA sequencing was performed by the University of Texas, Institute for Cellular and Molecular Biology DNA Core Facility using the capillary-based 3730 DNA analyzer from Applied Biosystems (Foster City, CA). Analysis of DNA sequences was carried out using MacVector 12.0.6. BLAST searches and other bioinformatic analyses were done using the National Center for Biotechnology Information (NCBI) and the Comprehensive Microbial Resource (CMR) databases. Pairwise alignments were carried out using ClustalW from within MacVector 12.0.6.

Construction of plasmids, strains, and chromosomal mutations. {#s3.4}
-------------------------------------------------------------

To create pVarA, the *varA* gene (VC1213) was amplified from *V. cholerae* strain C6706 by PCR using primers varA.F and varA.R. The resulting PCR product was cloned into pWKS30 digested with SmaI to yield pVarA. The *V. cholerae csrA* gene (VC0548) was cloned by PCR amplification of the *csrA* gene from strain N16961 using primers csrA3 and csrA4. The resulting fragment was cloned into the PmlI site of the single copy vector pCC1 to create pFcsrA, or into the SmaI site of pWKS30 to create pWCsrA.

To create strain N16961G (the wild-type strain, N16961, carrying a gentamicin cassette in the Tn7att site), we used the protocol described by McKenzie and Craig ([@B54]). pGRGgent1 (E. E. Wyckoff) was transferred to N16961 by bacterial conjugation, and transconjugants were selected at 30°C on polymyxin B and ampicillin for maintenance of the temperature-sensitive plasmid. Strains were grown at 42°C in order to facilitate loss of the plasmid and then screened on gentamicin and ampicillin to identify candidates that had lost the plasmid, but retained the gentamicin cassette. Gen^r^ Amp^s^ candidate N16961G strains were screened by PCR with primers IntF1 and IntR1 to verify insertion of the gentamicin cassette in the Tn7att site.

To create a chromosomal deletion of the *varA* gene, two fragments with a short overlap were generated by PCR using primer sets varA.F/VarA.Sma.1 and VarA.Sma.2/varA.R. The overlapping fragments were then used as the template to generate a splice overlap extension (SOE) PCR product using primers varA.F and varA.R. The final PCR fragment, Δ*varA*::SmaI, was cloned into the SmaI site of pWKS30, and the resulting plasmid was digested with SmaI to insert a chloramphenicol resistance cassette, yielding pWKS30 carrying Δ*varA*::*cam*. The Δ*varA*::*cam* fragment was subcloned as an XbaI/EcoRV fragment into pHM5 digested with XbaI/EcoRV to yield the allelic exchange construct pAMS30. To create the *V. cholerae csrA*.R6H point mutation, the *csrA*.R6H allele was amplified from strain N*varA*~L~-1 using KOD Hot Start polymerase and primers csrA3.Sal and csrA4.Bam. The PCR product was digested with SalI and BamHI and ligated into pHM5 digested with SalI and BglII to create allelic exchange construct pAMS31. To create the Tn*5* insertion in *csrA*, fragments with a short overlap were generated using primers csrA3 and csrA2 to amplify one segment from *V. cholerae* strain dl2395 (which carries the *csrA*::Tn*5* allele \[generously provided by B. Bassler\]), and primers csrA7 and csrA4 to amplify the other segment from the wild-type strain N16961. The overlapping segments were used as the template for SOE PCR with primers csrA3 and csrA4 to generate the complete *csrA*::Tn*5* fragment with flanking sequences. The *csrA*::Tn*5* fragment was cloned as a blunt fragment into pCVD442N digested with SmaI to create allelic exchange construct pAMS32. Allelic exchange constructs were transferred to *V. cholerae* strains via bacterial conjugation, and allelic exchange was carried out as described previously ([@B55], [@B56]).

SDS-PAGE and immunoblotting. {#s3.5}
----------------------------

Cultures were grown overnight in LB medium and diluted 1:100 into fresh medium, as described above and in the figure legends. Cultures were grown to the mid-log phase (optical density at 650 nm \[OD~650~\] of ≈0.5), and samples containing an equivalent number of cells were resuspended in Laemmli solubilization buffer ([@B57]). Whole-cell extracts were resolved by SDS-PAGE (10%) and visualized by Coomassie brilliant blue staining or electroblotted for 1.5 h at 45 V onto Hybond ECL (enhanced chemiluminescence) nitrocellulose (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, England). The positions of OmpT and OmpU were determined through comparisons of the wild-type strain with *ompT* and *ompU* mutants and by immunodetection of OmpT and OmpU ([@B58]) (data not shown). Immunodetection of ToxR was carried out using rabbit polyclonal anti-ToxR antiserum (diluted 1:1,000) (generous gift of R. K. Taylor), and horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Bio-Rad Laboratories, Hercules, CA) secondary antibody (diluted 1:10,000). Equal loading of the samples for immunoblotting was confirmed by evaluating the corresponding Coomassie-stained gel.

RNA isolation and microarray analysis. {#s3.6}
--------------------------------------

Strains were grown to mid-log phase (OD~650~ of ≈0.5) in T medium supplemented with 0.2% sucrose, 20 µM FeSO~4~, and a mix of vitamins, as described above. The cultures were then divided, and amino acid solutions were added to a final concentration of 50 mM total amino acids. Cultures were grown for an additional 15 min and then treated with an RNase-free solution of 95% absolute ethanol--5% phenol (pH 4.5), used at 20% vol/vol, and kept on ice. RNA was isolated from 10^9^ cells per sample using the RNeasy minikit (Qiagen) as per the manufacturer's instructions for isolation of total RNA from bacterial cells. Following purification, each RNA sample was treated with DNase I (Invitrogen) as per the manufacturer's protocol. The RNA samples were ethanol precipitated, dried, resuspended in RNase-free water, and quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). For microarray analysis, approximately 20 µg RNA per sample was used to generate cDNA for hybridization to *V. cholerae* NimbleChip_X4 microarray slides (NimbleGen Systems, Roche Diagnostics Operations, Inc., Indianapolis, IN). The microarray slides were processed by the Genomic Sequencing and Analysis Facility at the University of Texas, Austin, according to the NimbleGen system's protocols. The slides were scanned with GenePix 4000B Scanner (Axon Instruments, Molecular Devices, Sunnyvale, CA) and normalized using the GenePix software.

*In vivo* competition assays. {#s3.7}
-----------------------------

Animal experiments were performed according to protocols approved by the University of Texas Institutional Animal Care and Use Committee. *In vivo* competition assays were performed using 5-day-old BALB/c mice in a modified version of the protocol described by Taylor et al. ([@B33]). The two competing strains were the wild-type strain N16961G, containing an insertion of a gentamicin resistance cassette in the Tn*7att* site, and the NCsrA.R6H point mutant strain. We chose to mark the wild-type strain rather than the CsrA point mutant strain in order to avoid any adverse effects of the gentamicin cassette on the fitness of the mutant strain, which might skew the results. The infant mice were inoculated intragastrically with 50 µl saline containing 0.02% Evan's blue dye and approximately 10^5^ CFU of each competing strain grown to the mid-log phase in LB medium. The inoculation mixture was also diluted and plated, first on medium containing an antibiotic permissive for all *V. cholerae* El Tor stains (polymyxin B) and then on selective medium by patching in order to assess the input ratio of mutant to wild-type bacteria in the inoculum. The mice were sacrificed after 18 h, and the intestines were removed. The intestines of all the animals were visibly distended, consistent with significant fluid accumulation due to *V. cholerae* infection. The intestines were homogenized in 10 ml of sterile saline, and serial dilutions were plated on medium allowing recovery of both strains. Replica plating on differential medium by patching was then performed to determine the viable counts for each competing strain. The output ratios were normalized to the input ratios to determine the competitive index (CI): CI = (mutant output/wild-type output)/(mutant input/wild-type input). Differential medium patching was performed on up to 230 recovered colonies from each mouse, setting the limits of detection for the competitive index at approximately 0.005. Examples of both gentamicin-sensitive and -resistant colonies recovered from infection were analyzed by sequencing to verify the presence or absence, respectively, of the point mutation in the *csrA* gene.

SUPPLEMENTAL MATERIAL {#sm1}
=====================
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The wild-type strain N16961 (WT) and strain N*varA*~L~-1 (Δ*varA*::*cam*; *csrA*.R6H) were grown overnight in LB broth and then subcultured 1:100 into fresh LB broth and grown to stationary phase. The experiment was performed at least three times, but only one representative experiment is shown. Download

###### 

Figure S1, EPS file, 0.5 MB

###### 

Expression of wild-type *csrA* in the wild-type (VarA^+^) background does not disrupt the normal OMP expression pattern in response to the NRES mix. The wild-type parental strain N16961 was transformed with either pWCsrA or pFCsrA, and the resulting strains were assayed for their OMP profile. Strains N16961 (WT), N16961/pWKS30 (vector control strain), N16961/pWCsrA, N16961/pCC1 (vector control strain), and N16961/pFCsrA were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were grown to the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained with Coomassie blue. Download
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Figure S2, EPS file, 0.9 MB

###### 

A Tn*5* insertion at the 3′ end of the *csrA* gene abolishes the ToxR and OMP response to NRES. (A) The wild-type strain N16961 (WT) and the *csrA*::Tn*5* derivative were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue. (B) The whole-cell preparations from panel A were resolved by SDS-PAGE and immunoblotted using polyclonal anti-ToxR antisera. Download
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Figure S3, EPS file, 1.1 MB

###### 

Response of strain C6706 to NRES. C6706 was grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in the mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (top panel) or immunoblotted using polyclonal anti-ToxR antisera (bottom panel). Download
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Figure S4, EPS file, 0.7 MB

###### 

Microarray analysis of gene expression by *V. cholerae* grown in T medium, T medium plus NRES, and T medium plus Asp. Shown are the *V. cholerae* genes for which the transcript level was altered more than 2-fold in response to NRES.
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Table S1, XLSX file, 0.1 MB
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Effect of mutations on the OMP response to NRES.
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Table S2, DOCX file, 0.1 MB
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Bacterial strains and plasmids used in this study.
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Table S3, DOCX file, 0.1 MB
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PCR primers used in this study.
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Table S4, DOCX file, 0.1 MB
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